April 26, 2007

Johnson & Johnson Announces Dividend Increase of 10.7%

NEW BRUNSWICK, N.J., April 26, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 10.7% increase in the quarterly dividend rate, from $.375 per share to $.415 per share. The increase was announced this morning at the Annual Shareholders Meeting in New Brunswick, N.J.

"In recognition of our solid results in 2006, our strong financial position, and our confidence in the future of the corporation, the Board has voted to increase our dividend for the 45th consecutive year," said William C. Weldon, Chairman and Chief Executive Officer of the Company.

At the new rate, the indicated dividend on an annual basis is $1.66 per share compared to the previous rate of $1.50 per share. The next quarterly dividend is payable on June 12, 2007 to shareholders of record as of May 29, 2007.

Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 250 Johnson & Johnson operating companies employ approximately 121,000 men and women in 57 countries and sell products throughout the world.

SOURCE Johnson & Johnson

Media, Jeffrey J. Leebaw, +1-732-524-3350, +1-732-821-6007, or Bill Price,
+1-732-524-6623, cell, +1-732-668-3735, or Investors, Louise Mehrotra,
+1-732-524-6491, or Stan Panasewicz, +1-732-524-2524, or Lesley Fishman,
+1-732-524-3922, all of Johnson & Johnson
http://www.jnj.com/

Copyright (C) 2007 PR Newswire. All rights reserved

News Provided by COMTEX


Close window | Back to top

Copyright 2013 Johnson & Johnson

This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.